Back to funds

GILEAD SCIENCES, INC.

institutionalUpdated 16 days ago

Managed by Gilead Sciences, Inc. • Latest filing Q3 2026

Portfolio value
$1.5B
Q3 2026
Filings
5
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-18.3%
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 5 quarters

Show data table
PeriodPortfolio value
Q3 2025$1.8B
Q4 2025$1.9B
Q1 2026$2.1B
Q2 2026$1.6B
Q3 2026$1.5B

Top holdings

5 positions as of Q3 2026

View filing
R

Arcus Biosciences Inc.

Unchanged
Value
$811.7M
Shares
31.42M
% Port
55.45%
G

Lakefront Biotherapeutics

Unchanged
Value
$501.3M
Shares
16.71M
% Port
34.24%
A

Assembly Biosciences Inc.

Unchanged
Value
$116.9M
Shares
4.98M
% Port
7.99%
?
4.N/A

Kyverna Therapeutics Inc.

Unchanged
Value
$28.1M
Shares
4.13M
% Port
1.92%
?
5.N/A

Xilio Therapeutics Inc.

Unchanged
Value
$5.9M
Shares
650.4K
% Port
0.40%

Explore